Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281099 · ClinicalTrials.gov registry record · NA
Managed Ventricular Pacing ("MVP") Trial
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- NA
- Development phase
- 1,031
- Enrollment target
NCT00281099: Clinical Trial NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00281099 is a NA study that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,031 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281099, a NA study, was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,031 participants
- Enrollment target
Study Summary
The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ICD and the status of congestive heart failure.
Primary Outcome
A composite endpoint of all cause mortality and HF hospitalizations or urgent care. (Emergency Department, Urgent Clinic visits, or hospitalizations wiht intravenous medications for HF)
Interventions
- DEVICE ICD (Implantable Cardioverter Defibrillator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,031 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-07 |
| Phase | NA |
Why NCT00281099 stopped before completion
NCT00281099 is an interventional study that assigns participants to a tested intervention. Its 1,031 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 1 intervention - of which ICD (Implantable Cardioverter Defibrillator) is the first listed.
NCT00281099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281099 about?
NCT00281099 is a clinical study titled "Managed Ventricular Pacing ("MVP") Trial". The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ...
What is the current status of trial NCT00281099?
This trial is currently terminated. It is a NA study. The enrollment target is 1,031 participants. The study started on 2004-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00281099?
The interventions under investigation include: ICD (Implantable Cardioverter Defibrillator) (DEVICE).
Who is sponsoring clinical trial NCT00281099?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00281099's enrollment target sits among peer trials
1,031 103rd of 2000 higher than 1,898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia